Allspring Global Investments
NVAX icon

Allspring Global Investments’s Novavax NVAX Stock Holding History

Allspring Global Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-27,957
Closed -$266K – 1744
2025
Q3 		$266K Sell
27,957
-36
-0.1% -$280 ﹤0.01% 1505
2025
Q2 		$185K Buy
+27,993
New +$185K ﹤0.01% 1551
2024
Q4 		– Sell
-1,810
Closed -$22.9K – 2196
2024
Q3 		$22.9K Hold
1,810
– – ﹤0.01% 1981
2024
Q2 		$22.9K Buy
+1,810
New +$18.2K ﹤0.01% 2097
2023
Q4 		– Sell
-12,075
Closed -$87.4K – 2570
2023
Q3 		$87.4K Buy
12,075
+9,528
+374% +$76.1K ﹤0.01% 2052
2023
Q2 		$18.9K Hold
2,547
– – ﹤0.01% 2467
2023
Q1 		$17.6K Hold
2,547
– – ﹤0.01% 2525
2022
Q4 		$26.2K Sell
2,547
-22,051
-90% -$389K ﹤0.01% 2532
2022
Q3 		$447K Buy
24,598
+16,336
+198% +$708K ﹤0.01% 1607
2022
Q2 		$424K Sell
8,262
-7,839
-49% -$406K ﹤0.01% 1619
2022
Q1 		$1.19M Buy
16,101
+6,871
+74% +$613K ﹤0.01% 1783
2021
Q4 		$1.32M Buy
+9,230
New +$1.59M ﹤0.01% 1767

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's NVAX Position: Q4 2025 in Review

Allspring Global Investments sold out of Novavax (NVAX) in Q4 2025, closing a stake of 27,957 shares — an estimated $266K sold.

Allspring Global Investments first reported a position in NVAX in Q4 2021 and held it in 12 quarters. The position peaked at $1.32M in Q4 2021. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

  • Allspring Global Investments reported no remaining Novavax position as of Q4 2025 after selling out during the quarter.
  • Allspring Global Investments sold 27,957 Novavax shares in Q4 2025, an estimated $266K.
  • Allspring Global Investments first reported a position in Novavax in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Novavax position peaked at $1.32M in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on Allspring Global Investments's 13F filing for Q4 2025, filed 15 Jan 2026.